Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v8-FR
Language French French
Date Updated 2023-04-18 2023-04-04
Drug Identification Number 02269619 02269619
Brand name SANDOZ GLIMEPIRIDE SANDOZ GLIMEPIRIDE
Common or Proper name GLIMEPIRIDE GLIMEPIRIDE
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients GLIMEPIRIDE GLIMEPIRIDE
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30TAB 30TAB
ATC code A10BB A10BB
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-03-13 2023-03-13
Estimated end date 2023-04-21 2023-04-21
Actual end date 2023-04-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments